Crowley John F
- SEC CIK
- 0001400973
No open-market purchases or sales filed in the past year.
Current role at each company
- FOLD Amicus Therapeutics, Inc.Executive Chairmanas of Mar 15, 2024
- NTLA Intellia Therapeutics, Inc.Directoras of Jun 16, 2023
- TRDA Entrada Therapeutics, Inc.Directoras of Jun 12, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Crowley John F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FOLD Amicus Therapeutics, Inc.
Executive Chairman57 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 (view filing) | Jan 10 | 65 days | Crowley John FExecutive Chairman | SSale | −31.6K | $13.65 | −$431.5K | −3.3%927.0K after | Amended10b5-1 |
| Mar 5, 2024 (view filing) | Mar 1 | 4 days | Crowley John FExecutive Chairman | SSale | −29.2K | $13.35 | −$389.6K | −4.8%573.5K after | 10b5-1 |
| Feb 20, 2024 (view filing) | Feb 15 | 5 days | Crowley John FExecutive Chairman | SSale | −31.6K | $13.81 | −$436.6K | −4.3%697.6K after | 10b5-1 |
| Feb 5, 2024 (view filing) | Feb 1 | 4 days | Crowley John FExecutive Chairman | SSale | −31.6K | $12.62 | −$399.0K | −4.0%750.8K after | 10b5-1 |
| Jan 24, 2024 (view filing) | Jan 22 | 2 days | Crowley John FExecutive Chairman | SSale | −55.3K | $12.36 | −$683.8K | −6.6%782.5K after | 10b5-1 |
| Jan 18, 2024 (view filing) | Jan 16 | 2 days | Crowley John FExecutive Chairman | SSale | −31.6K | $12.78 | −$404.0K | −3.6%837.8K after | 10b5-1 |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Crowley John FExecutive Chairman | SSale | −6.04K | $12.66 | −$76.5K | −0.7%877.7K after | 10b5-1 |
| Dec 5, 2023 (view filing) | Dec 1 | 4 days | Crowley John FExecutive Chairman | SSale | −6.04K | $11.08 | −$67.0K | −0.7%883.8K after | 10b5-1 |
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Crowley John FExecutive Chairman | SSale | −6.04K | $10.84 | −$65.5K | −0.7%889.8K after | 10b5-1 |
| Nov 3, 2023 (view filing) | Nov 1 | 2 days | Crowley John FExecutive Chairman | SSale | −6.04K | $10.97 | −$66.3K | −0.7%895.9K after | 10b5-1 |
TRDA Entrada Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2022 (view filing) | Jan 12 | 1 day | Crowley John FDirector | PPurchase | +5.00K | $9.72 | +$48.6K | New position5.00K after |
NTLA Intellia Therapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 13, 2021 (view filing) | Oct 11 | 2 days | Crowley John FDirector | SSale | −2.50K | $119.55 | −$298.9K | −54.4%2.09K after | |
| Oct 7, 2021 (view filing) | Oct 5 | 2 days | Crowley John FDirector | SSale | −10.0K | $130.54 | −$1.31M | −82.7%2.09K after | 5 lots |